It may lead to anemia, tingling sensation, numbness in hands and feet, and ataxia
The researchers also demonstrated that late-life MOTS-C treatment (initiated at 23.5 months, which is equivalent to roughly 70 human years) improved physical capacity and healthspan
This study is particularly valuable because using an active comparator controls for many confounding factors
Enjoy the advantages of NAD+ therapy in the comfort of your home or office with our expert care
But they also note that they could not conclude this with certainty without further studies of the drug
This Website does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on this website